How the Cancer Care Team is Like a Symphony Orchestra

Video

Often, patients with cancer will come into contact with only a handful of members of their care team: a primary care physician or oncologist, perhaps a nurse or two. But as Dr. Phillip J. Koo explained, it helps to view the cancer care team – including those who a patient may never see – with a wider lens.

Often, patients with cancer will come into contact with only a handful of members of their care team: a primary care physician or oncologist, perhaps a nurse or two. But as Dr. Phillip J. Koo explained, it helps to view the cancer care team – including those who a patient may never see – with a wider lens.

In a recent interview with CURE®, Koo, the chief of diagnostic imaging at Banner MD Anderson Cancer Center in Phoenix, suggested thinking of the larger team of doctors and even researchers as an orchestra, working together to treat patients.

Additionally, Koo went on to note, patients can work with that larger team to stay up to date on the evolving nature of cancer research by keeping an open line of communication with their doctors.

Transcription:

CURE®: How is cancer care like an orchestra?

Koo: I think sometimes we look at cancer care with too narrow of a lens. We think, oh, you know, I just need one person and they're the one who treats my cancer. In reality, there's so many people. There are 30, 40, 50 people that are critical parts of the team that can really make a difference in your cancer care journey.

And that's why I think a lot of times we focus sometimes on a trio of providers – medical oncologist, surgical oncologist and radiation oncologist – but I think what we're recognizing it really is a symphony orchestra that's needed to really coordinate your care, integrate your care and also stay up on the latest developments because it's changing so rapidly.

And the beauty of a lot of what we're able to do in our center, and a lot of centers able to do, is really teach each other. And there's nothing wrong in saying that we don't know everything. Even myself, who I spent a lot of my career sort of focusing on prostate cancer, I learn something new every day. And it's actually very exciting to listen to other people speak and talk. And oftentimes, there's no black or white answer as well. And that's where education and learning is even more important, because you need to tease out those different elements that help us make a better educated decision in the end in partnership with our patients.

The field of cancer research is always evolving. How can patients work with their care team to stay informed?

If it's confusing for me at times, it's going to be confusing for patients as well. There's no doubt about it. And it's really hard to come up with a great solution for this, you know. You can read things that are on the internet, or things that were published a year or two years ago. And today, some of that is going to be out of date. And it's hard to sort of reconcile that because, you know, one year ago isn't too long. But it's important to sort of continue having that dialogue, and I think, you know, encouraging that dialogue is a good thing.

Second opinions are good things too. You know, this is something that I stress, whenever someone starts on this journey of cancer, whatever it might be, you only have one chance to get it right up front. And with that, I think having multiple people sort of give their teams give (their) input and recommendation is a good thing. It helps the patient and their family make a better-informed decision with no regrets because, again, it's always changing. And I would like to say that we're always up to date on everything, but we're not.

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.

Related Videos
Jessica McDade, B.S.N., RN, OCN, in an interview with CURE
Image of a woman with short blonde hair wearing a white blazer.
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Dr. Andrea Apolo in an interview with CURE
Dr. Kim in an interview with CURE
Dr. Nguyen, from Stanford Health, in an interview with CURE
Related Content